Literature DB >> 11310414

Caveat emptor: editors beware.

F X Vollenweider, R T Jones, M J Baggott.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11310414     DOI： 10.1016/S0893-133X(00)00170-6

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  6 in total

Review 1.  Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 2.  Serotonin neurotoxins--past and present.

Authors:  H G Baumgarten; L Lachenmayer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 3.  Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?

Authors:  William E Fantegrossi
Journal:  Psychopharmacology (Berl)       Date:  2006-03-23       Impact factor: 4.530

4.  MDMA Is Not Ecstasy: The Production of Pharmaceutical Safety through Documents in Clinical Trials.

Authors:  Katherine Hendy
Journal:  Med Anthropol Q       Date:  2020-05-18

5.  MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology.

Authors:  P Sáez-Briones; A Hernández
Journal:  Curr Neuropharmacol       Date:  2013-09       Impact factor: 7.363

6.  Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder.

Authors:  Sascha B Thal; Miriam J J Lommen
Journal:  J Contemp Psychother       Date:  2018-01-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.